Moneycontrol PRO
Contest Alert:1 day left to win Amazon vouchers worth Rs 5000. Take the MCPRO Quiz today to grab yours!

Jenburkt Pharma Standalone September 2021 Net Sales at Rs 35.51 crore, up 16.48% Y-o-Y

October 28, 2021 / 08:44 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Jenburkt Pharma are:

Net Sales at Rs 35.51 crore in September 2021 up 16.48% from Rs. 30.48 crore in September 2020.

Quarterly Net Profit at Rs. 7.97 crore in September 2021 up 40.52% from Rs. 5.67 crore in September 2020.

EBITDA stands at Rs. 11.46 crore in September 2021 up 39.76% from Rs. 8.20 crore in September 2020.

Jenburkt Pharma EPS has increased to Rs. 17.37 in September 2021 from Rs. 12.36 in September 2020.

Close

Jenburkt Pharma shares closed at 481.95 on October 26, 2021 (BSE) and has given 6.44% returns over the last 6 months and 34.60% over the last 12 months.

Jenburkt Pharma
Standalone Quarterly Resultsin Rs. Cr.
Sep'21Jun'21Sep'20
Net Sales/Income from operations35.5127.1830.48
Other Operating Income------
Total Income From Operations35.5127.1830.48
EXPENDITURE
Consumption of Raw Materials2.642.791.58
Purchase of Traded Goods5.864.507.10
Increase/Decrease in Stocks0.47-0.210.49
Power & Fuel------
Employees Cost9.128.657.92
Depreciation0.450.430.51
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses7.156.106.23
P/L Before Other Inc. , Int., Excpt. Items & Tax9.824.936.67
Other Income1.191.191.02
P/L Before Int., Excpt. Items & Tax11.016.127.69
Interest0.110.100.12
P/L Before Exceptional Items & Tax10.906.027.56
Exceptional Items------
P/L Before Tax10.906.027.56
Tax2.931.371.89
P/L After Tax from Ordinary Activities7.974.655.67
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period7.974.655.67
Equity Share Capital4.594.594.59
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS17.3710.1312.36
Diluted EPS17.3710.1312.36
EPS After Extra Ordinary
Basic EPS17.3710.1312.36
Diluted EPS17.3710.1312.36
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

first published: Oct 28, 2021 08:33 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark